Journal article

Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Richards, R., Burls, A., & Payne, N. (2000). Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit. BMJ (Clinical Research Ed.), 320(7247), 1475.

MLA Style

Richards, R., et al. “Cost Utility of Drugs for Multiple Sclerosis. Methods Used Don't Calculate True Benefit.” BMJ (Clinical Research Ed.), vol. 320, no. 7247, 2000, p. 1475.

Chicago Style

Richards, R, A Burls, and N Payne. 2000. “Cost Utility of Drugs for Multiple Sclerosis. Methods Used Don't Calculate True Benefit.” BMJ (Clinical Research Ed.) 320 (7247): 1475.
Share
Print

Authors

+ Richards, R More by this author

Role:: Author

+ Burls, A More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Primary Care Health Sciences
Role:: Author

+ Payne, N More by this author

Role:: Author

Journal:: BMJ (Clinical research ed.) More from this journal
Volume:: 320
Issue:: 7247
Pages:: 1475
Publication date:: 2000-05-01
EISSN:: 1756-1833
ISSN:: 0959-8138

Language:: English
Keywords:: Treatment Outcome

Multiple Sclerosis

Cohort Studies

Adjuvants, Immunologic

Survival Analysis

Interferon-beta

Humans
Pubs id:: pubs:116143
UUID:: uuid:8700e717-e04f-43a4-abd9-7d08e28cc838
Local pid:: pubs:116143
Source identifiers:: 116143
Deposit date:: 2012-12-19

Terms of use

Copyright date:: 2000

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP